[
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tabOnly the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCriteria for evaluating if there is a significant dose–response\nFigure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nResults from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788])For the left figure (3 knots) the model sum of square was 2098 (DF = 58) and model sum of square was 55 (DF = 2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "29\n\n\nIn summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tabOnly the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCriteria for evaluating if there is a significant dose–response\nFigure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nResults from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788])For the left figure (3 knots) the model sum of square was 2098 (DF = 58) and model sum of square was 55 (DF = 2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "29\n\n\nIn summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tabOnly the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCriteria for evaluating if there is a significant dose–response\nFigure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nResults from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788])For the left figure (3 knots) the model sum of square was 2098 (DF = 58) and model sum of square was 55 (DF = 2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "29\n\n\nIn summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tabOnly the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCriteria for evaluating if there is a significant dose–response\nFigure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nResults from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788])For the left figure (3 knots) the model sum of square was 2098 (DF = 58) and model sum of square was 55 (DF = 2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "29\n\n\nIn summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tabOnly the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCriteria for evaluating if there is a significant dose–response\nFigure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nResults from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788])For the left figure (3 knots) the model sum of square was 2098 (DF = 58) and model sum of square was 55 (DF = 2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "29\n\n\nIn summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tabOnly the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCriteria for evaluating if there is a significant dose–response\nFigure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nResults from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788])For the left figure (3 knots) the model sum of square was 2098 (DF = 58) and model sum of square was 55 (DF = 2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "29\n\n\nIn summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tabOnly the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCriteria for evaluating if there is a significant dose–response\nFigure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nResults from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788])For the left figure (3 knots) the model sum of square was 2098 (DF = 58) and model sum of square was 55 (DF = 2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "29\n\n\nIn summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tabOnly the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCriteria for evaluating if there is a significant dose–response\nFigure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nResults from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788])For the left figure (3 knots) the model sum of square was 2098 (DF = 58) and model sum of square was 55 (DF = 2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "29\n\n\nIn summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Assessment of clusters by expert judgement\n\nThe two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Sources of uncertainty were identified systematically in all parts of the assessment, starting from the planning stage (step B in Figure 5 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Uncertainties affecting the yes/no questions and non‐variable quantities were quantified using probabilities and probability distributions, respectively (step E in Figure 9 of EFSA Scientific Committee, 2018a), and combined by one‐dimensional Monte Carlo simulation (step F).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Additional sources of uncertainty, not yet quantified in the preceding steps, were taken into account when evaluating overall uncertainty (step G of Figure 9 and Section 16.1 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The analysis was divided into parts on three levels, corresponding to the structure of the hazard assessment, as illustrated in the upper part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For each of the 21 clusters in the other HOCs, uncertainty was quantified by means of two quantitative expert judgements, comprising a third level of division in the uncertainty analysis, as illustrated in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The combination was conducted in three steps, as illustrated in the lower part of Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The two questions for each cluster (see Figure 1) were assessed by expert judgement.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "This revised list comprises those sources of uncertainty which are additional in the sense used in EFSA's guidance on uncertainty (step G in Figure 9 of EFSA Scientific Committee, 2018a).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "The WG decided to address these using the simpler approach described in Figure 16 of EFSA Scientific Committee (2018a): revise the result of the preceding steps by expert judgement to take account of the additional uncertainties.",
    "figure_references": [
      {
        "figure_number": "Figure 16",
        "panel": "",
        "figure_key": "figure_16"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these, nine were further considered in the assessment (Figure 2), classified as having high (1 study) or limited relevance (8 studies).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "After a screening for the reliability and relevance of the results, six studies from four publications, all ranked as of limited relevance, were selected for further consideration (Figure 3 and Table 15).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 22 studies are reported in Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The overview of the evaluation and the summary of the test results from the 21 studies are reported in Figure 5 and in Table 16.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The summary of the evaluation and the results from the 5 studies are reported in Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The methods used to quantify the combined impact of the uncertainties affecting the hazard characterisation for HOCs other than genotoxicity are described in Section 2.3.4.1, in which an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The cpfs for the 21 clusters were then combined to produce overall cpfs quantifying uncertainty about the estimated lowest BMD across all the 21 clusters, as illustrated diagrammatically in Figure 1 in Section 2.3.4.1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "These revised judgements were used to produce revised overall cpfs quantifying uncertainty about the estimated lowest BMD across all 21 clusters, which are shown in Figure 7.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The horizontal axis of Figure 7 shows the range of doses in which the estimated lowest BMD across all 21 clusters is considered to lie.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Thus Figure 7 can be used to derive probabilities for the estimated lowest BMD across all 21 clusters being either above or below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The black dashed curves in Figure 7 are lower and upper bounds for the overall enveloped cpf, which reflect the combined effect of differences between experts in their judgements on each cluster.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The red solid curves in Figure 7 are lower and upper bounds for the overall averaged cpf, for which the cpfs of different experts for the same cluster are combined by averaging, giving equal weight to each expert.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The vertical blue dotted line in Figure 7 marks the dose corresponding to the RP (8.2 ng BPA/kg bw per day, expressed as HED) and the horizontal blue dotted lines show four estimates of the cumulative probability for this dose, i.e. the probability that the lowest BMD across all 21 clusters is below the RP.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The results in Figure 7 are an estimate of the combined impact of those uncertainties which were considered by the experts when making judgements on each of the 21 clusters included in the preceding steps.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "27\n\n\nThe cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The outcome of this analysis is shown by the cumulative probability functions in Figure 7, which quantify uncertainty about the dose at which the lowest BMD across all clusters would lie if all the uncertainties were resolved, assessed by a structured process of expert judgement (EKE).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Sensitivity analysis showed that the lowest part of the overall averaged cpf in Figure 7 (up to 5% probability on the vertical axis) was determined mainly by the cluster allergic lung inflammation and, in particular, by the study by O'Brien et al. (2014) [RefID 5462], reporting effects on production of pro‐inflammatory mediators and specific IgE in mice exposed prenatally to BPA.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Allergic lung inflammation was also the largest contributor to the middle part of the overall averaged cpf in Figure 7 (around 50% probability on the vertical axis), but here other clusters also contributed significantly (cellular immunity, inflammation and, to a lesser extent, male and female reproductive toxicity; see Figure D.13B in Appendix D).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "In the final step of the uncertainty analysis the CEP Panel assessed by expert judgement their probability that the lowest estimated BMD is below the RP, taking into account the estimates of this probability in Figure 7 and also additional uncertainties (Appendix D, Table D.5) that were not quantified earlier.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "The cumulative probability functions in Figure 7 show the probability of the lowest estimated BMD being below each dose on the horizontal axis, based on the expert judgements made in the uncertainty analysis.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Based on the lower and upper bounds for the averaged cpf in Figure 7, the probability of the lowest estimated BMD being below this dose would be between 43% and 57%, bracketing the 50% probability that would apply to a median estimate, as shown by the green solid lines in the figure.",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tabOnly the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nCriteria for evaluating if there is a significant dose–response\nFigure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nResults from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788])For the left figure (3 knots) the model sum of square was 2098 (DF = 58) and model sum of square was 55 (DF = 2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "29\n\n\nIn summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Raw data for Figure 8, Panel E, could not be assessed as they were not included in the publicly available data set for the study.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Examining the presence of dose–response in figures 8 and 9 in the Montévil et al. (2020) [RefID 13788] study under the NULL hypothesis that all groups are equal\n\n\n\n\n\n\n\n\n\nFigure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176\n\n\n\nOpen in a new tab.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Figure 8\nTotal\nModel\np‐value\n\n\nSSQ\nDF\nSSQ\nDF\n\n\n\n\nA – SD with 3D\n2,098\n58\n420\n5\n0.033\n\n\nB – Thickness mm\n23,941\n58\n4,263\n5\n0.058\n\n\nC – Dimension 3D\n0.4886\n58\n0.0545\n5\n0.266\n\n\nD – Angle between beginning and end\n149.4\n58\n12.8\n5\n0.431\n\n\nE – Dim3\nData not available\n\n\nF – Aspect Ratio\n14.92\n58\n2.36\n5\n0.095\n\n\n\nFigure 9\n\n\nSSQ\n\n\nDF\n\n\nSSQ\n\n\nDF\n\n\n\n\nA – Gland weight, PND90, stop dose\n4.990\n55\n0.751\n5\n0.136\n\n\nB – Density analysis PND90, continuous dose\n1,4250\n58\n1,580\n5\n0.269\n\n\nC – Density analysis, 6 months, continuous dose\n1,1975\n59\n1,235\n5\n0.303\n\n\nD – Density analysis, 9 months, stop dose\n9,358\n59\n1,208\n5\n0.176.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Only the mean variation of ductal thickness (SD with 3D, figure 8A) reached formal significance (p < 0.05), meaning that the mean response across all groups was significantly different.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For figure 8B, there was a borderline significant effect (p = 0.058) for the mean thickness of the epithelium, again driven by higher response in the 25 μg/kg bw dose group.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "For the aspect ratio (figure 8F), the 250 μg/kg bw per day dose groups was significantly different from the controls (p = 0.02, t‐test) but the F‐test for differences across dose groups did not reach formal significance.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "Panel F",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Taking figure 8A (the mean variation of ductal thickness) as an example of an outcome showing a potential dose–response, the shape of the dose–response was evaluated by modelling the data in PROAST using the following set of models (Table B.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Figure 9: In short, none of the models deviated significantly form the NULL model.",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "Significant dose–response could only be generated for figure 8B by overfitting the data using a restricting cubic spline as implemented in ‘proc glmselect’ in SAS (v9.2).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel B",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Results from fitting a restricted cubic spline using 3 and 4 knots to the data from figure 8A (Montévil et al., 2020 [RefID 13788]).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "In summary, based on a simple F‐test, only the results from figure 8A show any indication of significant dose–response.",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "Panel A",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "The methods used to identify sources of uncertainty and quantify their combined impact on the assessment are described in Section 2.3.4.1, where an overview of the approach is provided in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "The narrowing of the bounds in Figure 12 and the bar in Figure D.13A by about an order of magnitude on the dose scale (compared to the ‘all’ bar at the bottom of the graph) when allergic lung inflammation is excluded shows that the differences of opinion between experts for this cluster (which are apparent in Figures D.1, D.6 and D.7) make a large contribution to overall uncertainty about the estimated lowest BMD across all clusters.",
    "figure_references": [
      {
        "figure_number": "Figure 12",
        "panel": "",
        "figure_key": "figure_12"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nComparison of probability ranges provided by the experts for Question 3 with the probability ranges calculated from their assessments for Questions 1 and 2, showing the adjustments made by the experts to account for the additional uncertainties listed in Table D.5\nThe final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "The final judgements of the experts for Question 3 are shown in Figure D.18 and compared with their respective calculated probabilities based on their assessments of Questions 1 and 2 in Figure 19.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  },
  {
    "sentence": "Figure 19 shows that all of the experts judged that little or no adjustment was needed to their calculated probabilities to take account of the additional uncertainties in Table D.5, and this was confirmed by the discussion.",
    "figure_references": [
      {
        "figure_number": "Figure 19",
        "panel": "",
        "figure_key": "figure_19"
      }
    ]
  }
]